Nicholas Aquino
Internal Medicine · Buffalo, NYNPI 1710941521
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 270 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,911 and has fallen 93.6% since, to $250 in 2024. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $42.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$1K
- AbbVie$1K
- GSK$1K
- Boehringer Ingelheim$915
- Amgen$913
- plus $4K from 26 others
What the payments were for
- Food & beverage$11,31199%
- Education$1081%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 119 | $1,840 |
| AstraZeneca | 15 | $1,152 |
| AbbVie(2 entities) | 21 | $1,103 |
| GSK | 16 | $1,081 |
| Boehringer Ingelheim | 12 | $915 |
| Amgen | 16 | $913 |
| Sanofi-aventis U.S. LLC | 9 | $906 |
| Johnson & Johnson | 9 | $635 |
| Biohaven Pharmaceuticals, Inc. | 3 | $360 |
| Lilly USA, LLC | 13 | $294 |
| Gilead | 2 | $200 |
| Amarin Pharma, Inc. | 5 | $170 |
| Merck | 6 | $168 |
| Jazz Pharmaceuticals Inc. | 3 | $144 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Eisai Inc. | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Radius Health, Inc. | 1 | $125 |
| Baxter Healthcare | 2 | $117 |
| Abbott | 1 | $110 |
| Esperion Therapeutics, Inc. | 1 | $105 |
| Astellas Pharma US Inc | 1 | $100 |
| Daiichi Sankyo Inc. | 1 | $99 |
| Sanofi Pasteur Inc. | 3 | $54 |
| Genentech USA, Inc. | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Novartis | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,419 in reported general payments places this provider in the 90th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Buffalo
- Nicholas RobinsonBuffalo$2.9M
- Anthony MartinezBuffalo$1.6M
- Sanjay SethiBuffalo$733K
- Rosalind SulaimanBuffalo$145K
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Javier MoralesGreenvale$1.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.